Reports
Reports
Sale
The global mental health treatment market reached about USD 397.5 billion in 2023 and is expected to grow at a CAGR of 4.9% during the forecast period of 2024-2032. With the growing incidences of mental disorders, the market is expected to reach about USD 610.1 billion by 2032. The growth driving factors include increased mental health awareness and high telemedicine adoption.
Mental health comprises of emotional, psychological, and social well-being. It has an impact on how one thinks, feels, and acts. It also influences how one deals with stress, interacts with others, and makes decisions. Mental health is essential throughout life, from childhood and adolescence to adulthood.
If a person has mental health issues, their thinking, mood, and behaviour may be affected throughout life. There are many factors that lead to mental health issues. Genes and brain biochemistry are examples of biological influences, whereas trauma and abuse are examples of life experiences.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
There is no physical test or scan that can consistently determine whether a person has developed a mental disorder. People should, however, be on the lookout for the following symptoms of a mental health disorder, some of which are as follows:
There are numerous approaches to deal with mental health issues. Treatment is extremely personalised, and what works for one person may not work for another. Some techniques or treatments are more effective when used in conjunction with others. A person suffering from a persistent mental disease may make varied decisions throughout the life.
A few treatment options are psychotherapy, medication, and self-help, among others.
According to the global mental health treatment market research report, the market can be categorised into the following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Disorder
Market Breakup by Services
Market Breakup by Treatment Techniques
Market by Age
Market by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In 2019, 1 in every 8 individuals or 970 million people worldwide, suffered from a mental disorder, with anxiety and depression being the most frequent. Because of the COVID-19 pandemic, the number of people living with anxiety and depression increased considerably in 2020. Initial estimates reveal a 26% and 28% increase in anxiety and severe depressive disorders, respectively, in just 1 year. While there are excellent prevention and treatment alternatives, most persons with mental problems do not have access to them. Many people face stigma, discrimination, and infringement of their human rights.
Several governments are increasing their investments in telecommunications and digital technologies, as well as hiring more mental health specialists. Concurrently, mental health awareness programmes are expanding dramatically, resulting in positive market trends. Furthermore, the market is predicted to develop as healthcare infrastructure improves, as occurrences of depression cause disability increase, as the geriatric population grows.
Globally, increasing digitalisation and smartphone and internet adoption are predicted to expand the use of mental health apps. Furthermore, trends shifting from traditional methods of care toward patient-centric and personalised care are encouraging the use of mental health applications. As a result, rising investments in digital mental health are expected to create lucrative prospects for market expansion.
The report gives an in-depth analysis of the key players involved in the global mental health treatment market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Disorder |
|
Breakup by Services |
|
Breakup by Treatment Techniques |
|
Breakup by Age |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Mental Health Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Global Mental Health Epidemiology Analysis
5.1 Epidemiology Overview (2017-2032)
5.2 North America Mental Health Epidemiology (2017-2032)
5.3 Europe Mental Health Epidemiology (2017-2032)
5.4 Asia-Pacific Mental Health Epidemiology (2017-2032)
5.5 Latin America Mental Health Epidemiology (2017-2032)
5.6 Middle East & Africa Mental Health Epidemiology (2017-2032)
6 Global Mental Health Treatment Market Overview
6.1 Global Mental Health Treatment Historical Value (2017-2023)
6.2 Global Mental Health Treatment Forecast Value (2023-2032)
7 Global Mental Health Treatment Market Landscape
7.1 Global Mental Health Treatment Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Global Mental Health Treatment Product Landscape
7.2.1 Analysis by Disorder
7.2.2 Analysis by Services
7.2.3 Analysis by Treatment
8 Global Mental Health Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Mental Health Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Mental Health Treatment Market Segmentation
11.1 Global Mental Health Treatment Market by Disorder
11.1.1 Market Overview
11.1.2 Mood Disorders
11.1.3 Personality Disorders
11.1.4 Psychotic Disorders
11.1.5 Eating Disorders
11.1.6 Trauma-Related Disorders
11.1.7 Substance Abuse Disorders
11.1.8 Others
11.2 Global Mental Health Treatment Market by Services
11.2.1 Market Overview
11.2.2 Emergency Mental Health Services
11.2.3 Outpatient Counselling
11.2.4 Home Treatment Services
11.2.5 Inpatient Hospital Treatment Services
11.2.6 Others
11.3 Global Mental Health Treatment Market by Treatment Techniques
11.3.1 Market Overview
11.3.2 Intervention Counselling
11.3.3 Individualized Therapy
11.3.4 Family Counselling
11.3.5 Discharge Planning
11.3.6 Psychological Intervention
11.3.7 Cognitive Behaviour Therapy
11.3.8 Dialectical Behaviour Therapy
11.3.9 Medication Evaluation and Therapy
11.3.10 Psychotherapy
11.3.11 Trauma Therapy
11.3.12 Others
11.4 Global Mental Health Treatment Market by Age
11.4.1 Market Overview
11.4.2 Pediatric
11.4.3 Adult
11.4.4 Geriatric
11.5 Global Mental Health Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Mental Health Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Mental Health Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Mental Health Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Others
15 Latin America Mental Health Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Mental Health Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 South Africa
16.5 Others
17 Patent Analysis
17.1 Analysis by Type of Patent
17.2 Analysis by Publication year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Regulatory Framework
22.1 Regulatory Overview
22.1.1 US FDA
22.1.2 EU EMA
22.1.3 INDIA CDSCO
22.1.4 JAPAN PMDA
22.1.5 Others
23 Supplier Landscape
23.1 Acadia Healthcare
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Sevita (The Mentor Network)
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Universal Health Services, Inc.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Behavioral Health Network, Inc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 CareTech Holdings plc
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Strategic Behavioral Health LLC
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Ascension Seton
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Takeda Pharmaceutical Company Limited
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Teijin Limited
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Johnson & Johnson, Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Global Mental Health Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market size was valued at nearly USD 397.5 billion in 2023.
The market is expected to grow at a CAGR of 4.9 % during the forecast period of 2024-2032.
The market is expected to reach about USD 610.1 billion by 2032.
The increased awareness about the severity of mental health and the rising availability of treatment will propel the market growth.
The regions included in this market are North America, Latin America, Asia Pacific, Europe, and Latin America. North America accounts for the largest share of the market owing to the easy availability of treatment and increased awareness of the mental health.
Mental health disorders are usually caused by stress, physical and mental trauma, social stigma, and bereavement, among others.
Mental tiredness can occur when your brain is overstimulated or is required to maintain an excessive level of activity without rest.
The key companies in the global market include Acadia Healthcare, Sevita (The Mentor Network), Universal Health Services, Inc., Behavioral Health Network, Inc., CareTech Holdings plc, Strategic Behavioral Health LLC, Ascension Seton, Takeda Pharmaceutical Company Limited, Johnson & Johnson, Inc., and Teijin Limited.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.